Bill > HB1114

This bill requires health insurance providers in North Dakota to limit out-of-pocket costs for insulin drugs and related medical supplies to $25 per 30-day supply. The legislation defines "insulin drug" as prescription medication containing insulin to treat diabetes, excluding devices like insulin pumps or continuous glucose monitors. The covered medical supplies include items such as blood glucose meters, test strips, lancets, ketone testing supplies, glucagon, insulin pen needles, and insulin syringes. Insurance companies, health service corporations, and health maintenance organizations must ensure their health benefit plans comply with these cost restrictions, preventing them from charging patients more than the specified limits. The bill includes a provision that these cost limitations do not apply if they would compromise a high-deductible health plan's eligibility for a health savings account, and the requirements do not apply to Medicare Part D prescription drug coverage. This legislation aims to make insulin and related medical supplies more affordable for patients with diabetes by capping their monthly expenses for these essential healthcare items.

Budget and Finance, Government Affairs, Military Affairs and Security

Government and Veterans Affairs (H)

https://ndlegis.gov/assembly/69-2025/regular/bill-overview/bo1114.html